4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride

We are 4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride CAS:84449-80-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride
CAS.NO:84449-80-9
Synonyms:4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride
4-[2-(Piperidin-1-yl)ethoxy]benzoic acid hydrochloride
 
Physical and Chemical Properties:
Boiling Point 413.2ºC at 760 mmHg
Melting Point 267-271ºC dec.
Molecular Formula C14H20ClNO3
Molecular Weight 285.767
Flash Point 203.7ºC
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Raloxifene(CAS:84449-90-1).

4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride


Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.3,5-Dichloroaniline The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.179688-27-8 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.1,3,5-Tris(3,3,3-trifluoropropyl)methylcyclotrisiloxane Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.

Related Products
Product Name
11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole View Details
5-Fluoro-2-nitrobenzoic acid View Details
1-Bromo-2,4,6-trifluorobenzene View Details
3-Amino-2-chloropyridine manufacturer Diethyl(3-pyridyl)borane manufacturer Fmoc-D-Trp(Boc) manufacturer 2,4-Dichloro-5-nitrobenzotrifluoride manufacturer (2S,6aS)-Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride manufacturer